Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | -2.00K | -25.00K | -57.00K |
EBITDA | -178.00K | -254.00K | -582.00K | -961.00K | -1.29M |
Net Income | -178.00K | -254.00 | -584.00K | -986.00K | -1.37M |
Balance Sheet | |||||
Total Assets | 733.00K | 976.00K | 1.54M | 2.29M | 1.66M |
Cash, Cash Equivalents and Short-Term Investments | 714.00K | 938.00K | 1.51M | 2.24M | 1.51M |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K |
Total Liabilities | 17.00K | 85.00K | 405.00K | 585.00K | 857.00K |
Stockholders Equity | 716.00K | 891.00K | 1.14M | 1.70M | 804.00K |
Cash Flow | |||||
Free Cash Flow | -240.00K | -561.00K | -734.00K | -1.08M | -1.10M |
Operating Cash Flow | -240.00K | -561.00K | -734.00K | -1.08M | -1.10M |
Investing Cash Flow | -250.00K | 0.00 | 0.00 | 0.00 | 0.00 |
Financing Cash Flow | 0.00 | 0.00 | 0.00 | 1.81M | 2.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
51 Neutral | $7.92B | -0.43 | -41.67% | 2.21% | 22.29% | -1.85% | |
35 Underperform | C$465.73K | ― | -14.21% | ― | ― | 8.35% | |
30 Underperform | C$308.26K | 0.73 | 8.55% | ― | ― | ― | |
― | C$1.04M | ― | -16.58% | ― | ― | ― | |
― | C$810.00K | ― | ― | ― | ― | ||
― | $557.13K | ― | ― | ― | ― | ||
― | C$858.60K | ― | ― | ― | ― |
Vaxil Bio Ltd. announced the mutual termination of its definitive agreement with Green Data Center Real Estate Inc. This move will see Green Data Centers repay a loan from Vaxil by July 2025 and issue shares worth $50,000 to Vaxil. Despite this, Vaxil remains committed to exploring other strategic options to maximize shareholder value, including the further development of its existing assets.